Cedar Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Cedar Wealth Management's GILD Position: Q1 2025 in Review
Cedar Wealth Management sold out of Gilead Sciences (GILD) in Q1 2025, closing a stake of 160 shares — an estimated $14.8K sold.
Cedar Wealth Management first reported a position in GILD in Q1 2018 and held it in 23 quarters. The position peaked at $112K in Q4 2022. 2,013 funds tracked by Wall St. Rank hold GILD as of Q1 2025.
- Cedar Wealth Management reported no remaining Gilead Sciences position as of Q1 2025 after selling out during the quarter.
- Cedar Wealth Management sold 160 Gilead Sciences shares in Q1 2025, an estimated $14.8K.
- Cedar Wealth Management first reported a position in Gilead Sciences in Q1 2018 and held it in 23 quarters.
- Cedar Wealth Management's Gilead Sciences position peaked at $112K in Q4 2022.
- 2,013 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2025.
Based on Cedar Wealth Management's 13F filing for Q1 2025, filed 9 May 2025.